Medicus Pharma (MDCX) Cash from Financing Activities (2024 - 2025)
Medicus Pharma's (MDCX) quarterly Cash from Financing Activities came in at $6.7 million in Q4 2025, up 224.6% YoY from $2.0 million in Q4 2024, and down 35.85% on a QoQ basis from $10.4 million in Q3 2025.
Medicus Pharma (MDCX) Cash from Financing Activities (2024 - 2025) Analysis & Trends
Medicus Pharma (MDCX) has 2 years of Cash from Financing Activities data on file, last reported at $6.7 million in Q4 2025.
- Quarterly Cash from Financing Activities rose 224.6% year-over-year to $6.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $31.9 million (up 151.65% YoY) and the FY2025 annual result came in at $31.9 million, up 151.65% from the prior year.
- Cash from Financing Activities retreated to $6.7 million in Q4 2025, from $10.4 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $11.2 million in Q2 2025 to a low of $2.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -3.89 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Medicus Pharma | 14.88 Mn | -298,205.43 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.65 Mn |
| Dec 31, 2025 | 6.65 Mn |
| Sep 30, 2025 | 10.37 Mn |
| Sep 30, 2025 | 10.37 Mn |
| Jun 30, 2025 | 11.16 Mn |
| Jun 30, 2025 | 11.16 Mn |
| Mar 31, 2025 | 3.76 Mn |
| Mar 31, 2025 | 3.76 Mn |
| Dec 31, 2024 | 2.05 Mn |
| Dec 31, 2024 | 2.05 Mn |
| Jun 30, 2024 | 10.64 Mn |
| Jun 30, 2024 | 10.64 Mn |